TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail

Clinical trial NCT05375461 · COMPLETED

Trial details

NCT number: NCT05375461
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HR-positive,HER2-negative in Advanced Breast Cancer

Start date: 2022-03-18
Primary completion: 2024-01-16
Enrollment: 293

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.